Effect of dronedarone on clinical end points in patients with atrial fibrillation and coronary heart disease: insights from the ATHENA trial

Ron Pisters, Stefan H. Hohnloser, Stuart J. Connolly, Christian Torp-Pedersen, Lisa Naditch-Brule, Richard L. Page, Harry J. G. M. Crijns*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)174-181
JournalEP Europace
Issue number2
Publication statusPublished - Feb 2014


  • Dronedarone
  • Atrial fibrillation
  • Coronary heart disease

Cite this